Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-27Clinical Trial Results: A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma [Phase 2]
A Phase 2 trial comparing inhaled PT007 (ASM_DI) to placebo and Ventolin in adults with asthma; results completed with posted results.
-
EMA approval · 2026-08-26EMA Authorised: Tezspire (tezepelumab) — AstraZeneca AB
Authorised status for Tezspire (tezepelumab) by AstraZeneca AB for asthma and sinusitis in the EMA, indicating market authorisation.
-
CLINICAL_TRIALS trial_result · 2026-08-21Clinical Trial Results: A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma [Phase 1]
Phase 1 clinical trial evaluating airway sensitivity reactions when using propellants HFA-152a vs HFA-134a in adults with mild asthma; resul…
-
EMA approval · 2026-08-19EMA Authorised: Nucala (Mepolizumab) — GlaxoSmithKline Trading Services Limited
EMA has authorised Nucala (mepolizumab) for asthma, confirming regulatory approval in the European Union.
-
EMA approval · 2026-08-18EMA Authorised: Dupixent (dupilumab) — Sanofi Winthrop Industrie
The EMA has authorised Dupixent (dupilumab) for multiple indications including atopic dermatitis, prurigo, esophageal diseases, asthma, and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA approval · 2026-08-13EMA Authorised: Exdensur (depemokimab) — GlaxoSmithKline Trading Services Limited
EMA authorised Exdensur (depemokimab) for asthma and nasal polyps under GlaxoSmithKline Trading Services Limited.
-
CLINICAL_TRIALS trial_result · 2026-08-10Clinical Trial Results: Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma. [Phase 3]
Phase 3 trial comparing Foster 100/6 mg NEXThaler to Foster 100/6 mg pMDI in patients with controlled asthma; results completed and posted.
-
EMA approval · 2026-07-22EMA Authorised: Nucala (Mepolizumab) — GlaxoSmithKline Trading Services Limited
Authorisation of Nucala (mepolizumab) for asthma by EMA, confirming its market approval in the European Union.
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: Developing a Childhood Asthma Risk Passive Digital Marker [NA]
A terminated clinical trial evaluating a passive digital marker to assess childhood asthma risk; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication [Phase 3]
Phase 3 study evaluating lebekizumab in uncontrolled asthma patients on inhaled corticosteroids and a second controller, with completed resu…
-
CLINICAL_TRIALS trial_result · 2026-07-17Clinical Trial Results: A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma [Phase 3]
Phase 3 trial results evaluating Lebrikizumab for efficacy and safety in adults with mild to moderate asthma have been completed with result…
-
CLINICAL_TRIALS trial_result · 2026-07-16Clinical Trial Results: Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States [Phase 4]
Phase 4 trial evaluating tezepelumab for effectiveness and safety in adults and adolescents with severe asthma in the United States; results…
-
CLINICAL_TRIALS trial_result · 2026-07-14Clinical Trial Results: Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma [Phase 2]
Phase 2 clinical trial results for ARS-1 or Albuterol in adults with persistent asthma have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-09Clinical Trial Update: REVErsing Airway Remodelling With Tezepelumab [Phase 3]
Phase 3 trial update on tezepelumab targeting airway remodelling in asthma; study completed.
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Sub-Sensitivity to Long-Acting Bronchodilators (LABA) [NA]
Clinical trial results evaluating sub-sensitivity to long-acting beta-agonist bronchodilators in asthma were completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) [Phase 3]
Phase 3 study LOGOS evaluated PT010 in adults and adolescents with inadequately controlled asthma; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Update: Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating the DASH dietary pattern's impact on quality of life and clinical outcomes in uncontrolled asthma, in…
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication [Phase 3]
Phase 3 clinical trial results for lebkreizumab in adolescents with uncontrolled asthma on inhaled corticosteroids and a second controller, …
-
CLINICAL_TRIALS trial_result · 2026-06-30Clinical Trial Results: Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) [Phase 3]
Phase 3 trial assessing PT010 in adults and adolescents with inadequately controlled asthma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-29Clinical Trial Results: Examining Changes in Nasal IL-1 During Acute Asthma Exacerbation in Adolescents
A completed clinical trial examining changes in nasal IL-1 during acute asthma exacerbations in adolescents.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA [Phase 3]
Phase 3 trial results for TRIple in asthma patients uncontrolled on medium-dose inhaled corticosteroid plus LABA have been completed.
-
CLINICAL_TRIALS trial_result · 2026-06-26Clinical Trial Results: Medication Adherence With Telehealthcare Medication Therapy Management [NA]
Completed clinical trial evaluating medication adherence with telehealthcare medication therapy management in uncontrolled asthma for young …
-
EMA approval · 2026-06-25EMA Authorised: Tezspire (tezepelumab) — AstraZeneca AB
The EMA has authorised Tezspire (tezepelumab) by AstraZeneca AB for therapeutic use in asthma and sinusitis.
-
CLINICAL_TRIALS trial_result · 2026-06-23Clinical Trial Results: AZithromycin Therapy in Preschoolers With a Severe Wheezing Episode Diagnosed at the Emergency Department [Phase 3]
Phase 3 trial evaluating azithromycin therapy in preschoolers with a severe wheezing episode in the emergency department; study terminated w…
-
CLINICAL_TRIALS trial_result · 2026-06-18Clinical Trial Results: Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma [Phase 3]
Phase 3 trial assessing tezepelumab for reducing oral corticosteroid use in adults with oral corticosteroid-dependent asthma; study terminat…